Please assess the completion status of the following clinical trial:

Trial Title: Atrioventricular Node Ablation in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age of 18-75 years~* CHF II-III NYHA~* Persistent/permanent AF requiring AV node ablation~* LVEF \< 45%~* Signed informed consent~* Able to complete all testing required by the clinical protocol~Exclusion Criteria:~* Myocardial infarction or stroke less than 3 months prior to randomization~* Patients who require revascularization, radiofrequency ablation of pulmonary veins and substrate of AF~* The congenital and acquired heart diseases, LV aneurysm, which requires a surgical correction~* Active inflammatory and autoimmune diseases of a myocardium~* The thyrotoxicosis~* The diseases that limit life expectancy (cancer, tuberculosis, etc.)~* Contraindications to anticoagulants administration at CHADS2\> 2~* Uncompliant patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- CRT (Type: EXPERIMENTAL): None
- pacemaker (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).